NETS

A New Dawn for CCUS After Five Decades of Ups and Downs

Retrieved on: 
수요일, 11월 23, 2022
Carbon, Consultant, Players, Agave americana, NETS, First Nations in Ontario, Investment, UN, Val Verde, Hope, DAC, Research, Climeworks, Revolution, Western world, Drax, COP26, Acceleration, MRV, Conference, NZE, Coal, FID, Inflation, IRA, Subscription business model, Blue, Hydrocarbon, EOR, International Energy Agency, Direct air capture, Renewable energy, Asian Infrastructure Investment Bank, United Nations, Growth, IEA, CCS, Policy, CO, Hydrogen, Iron, Carbon dioxide, Sleipnir, Carbon dioxide removal, Santos Basin, CDR, Iron & Steel Museum of Alabama, Cement, Petra Nova

However, despite the critical importance of the technology and substantial development to date, CCUS deployment has been slower than anticipated.

Key Points: 
  • However, despite the critical importance of the technology and substantial development to date, CCUS deployment has been slower than anticipated.
  • For further information on the CCUS market and its technologies, please refer to IDTechEx's report " Carbon Capture, Utilization, and Storage 2021-2040 ".
  • CCUS capacity growth has been around 2.3Mtpa of added capacity since 2010, with annual capture capacity reaching 41Mtpa of CO in 2020.
  • The first industrial large-scale CCUS project commenced operation about 50 years ago at the Val Verde natural gas processing plant in Texas, US.

A New Dawn for CCUS After Five Decades of Ups and Downs

Retrieved on: 
수요일, 11월 23, 2022
Carbon, Consultant, Players, Agave americana, NETS, First Nations in Ontario, Investment, UN, Val Verde, Hope, DAC, Research, Climeworks, Revolution, Western world, Drax, COP26, Acceleration, MRV, Conference, NZE, Coal, FID, Inflation, IRA, Subscription business model, Blue, Hydrocarbon, EOR, International Energy Agency, Direct air capture, Renewable energy, Asian Infrastructure Investment Bank, United Nations, Growth, IEA, CCS, Policy, CO, Hydrogen, Iron, Carbon dioxide, Sleipnir, Carbon dioxide removal, Santos Basin, CDR, Iron & Steel Museum of Alabama, Cement, Petra Nova

However, despite the critical importance of the technology and substantial development to date, CCUS deployment has been slower than anticipated.

Key Points: 
  • However, despite the critical importance of the technology and substantial development to date, CCUS deployment has been slower than anticipated.
  • For further information on the CCUS market and its technologies, please refer to IDTechEx's report " Carbon Capture, Utilization, and Storage 2021-2040 ".
  • CCUS capacity growth has been around 2.3Mtpa of added capacity since 2010, with annual capture capacity reaching 41Mtpa of CO in 2020.
  • The first industrial large-scale CCUS project commenced operation about 50 years ago at the Val Verde natural gas processing plant in Texas, US.

ORYZON Announces FDA Clearance of IND to Initiate a Collaborative Phase II Basket Study with Iadademstat in R/R Patients with Neuroendocrine Carcinomas (NECs)

Retrieved on: 
수요일, 11월 9, 2022
IND, Communication, Research, CNMV, Development, Sale, Person, NEC Laboratories America, Survival, Fox Chase Cancer Center, CRADA, Associate, Squamous cell carcinoma, Phase II, NETS, Forward-looking statement, Prevalence, Azacitidine, B cell, ISIN, FLT3, Prospectus, FCCC, Mercado, Cancer, Gastrointestinal tract, AML, Patient, MD, NCI, NET, Investigational New Drug, Cooperative research and development agreement, Hematological Cancer Research Investment and Education Act, Medulloblastoma, EHA, Acute myeloid leukemia, NEC, Mission statement, Public expenditure, Growth, FDA, GLOBE, Carcinoma, ORY, ESMO, Wilms' tumor, Spanish, Safety, LSD1, Genomics, ALICE, Prognosis, Pharmaceutical industry, SCLC, EU

Patients often rapidly develop progressive disease after first line cytotoxic chemotherapy and lack clearly efficacious second line treatment options.

Key Points: 
  • Patients often rapidly develop progressive disease after first line cytotoxic chemotherapy and lack clearly efficacious second line treatment options.
  • Response rates for NECs and SCLC in second line are generally less than 5% and 20%, respectively, and survival is measured in months.
  • There are very few treatment options for these patients and even fewer trials, which makes this effort even more important.
  • In total iadademstat has been dosed so far to more than 100 cancer patients in four clinical trials.

Ariceum Therapeutics and AmbioPharm Enter Strategic Manufacturing and Supply Partnership

Retrieved on: 
목요일, 10월 27, 2022
Biotechnology, Manufacturing, Health, Radiology, Pharmaceutical, Oncology, Other Science, Research, Other Manufacturing, Science, Clinical Trials, Biotechnology, LSP, Peptide, Polonium, CGMP, Neoplasm, Squamous cell carcinoma, Radium, Doctor of Philosophy, FDA, CDMO, Therapy, NETS, SCLC, Partnership, Radiopharmaceutical, Research, HealthCap, API, Cancer, SST2, Diagnosis, Neuroblastoma, Fine chemical, Medical imaging, Ipsen

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and systemic targetedradiation therapy of certain hard-to-treat cancers, and AmbioPharm, a global peptide contract development and manufacturing organization, today announce that they have entered into a strategic partnership for the manufacture and supply of peptide conjugates to be used by Ariceum in future clinical studies.

Key Points: 
  • Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and systemic targetedradiation therapy of certain hard-to-treat cancers, and AmbioPharm, a global peptide contract development and manufacturing organization, today announce that they have entered into a strategic partnership for the manufacture and supply of peptide conjugates to be used by Ariceum in future clinical studies.
  • AmbioPharm is supporting Ariceum with cGMP manufacturing and supply of peptide conjugates that will be radio-labelled as the radiopharmaceutical end-product used in upcoming clinical trials.
  • Manfred Rdiger, PhD, Chief Executive Officer of Ariceum Therapeutics, said: Ariceum is very pleased to be partnering with AmbioPharm.
  • Ariceum Therapeutics (Ariceum) is a private, clinical stage radiopharmaceutical company focused on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers.

New IDTechEx Report Explores the Carbon Dioxide Removal (CDR) Market Potential

Retrieved on: 
월요일, 10월 10, 2022
Carbon, Adoption, Bioenergy with carbon capture and storage, DACCS, Policy, IPCC, Paris, Climate, Carbon dioxide, Research, Investment, CDR, CO, NETS, Climate change, BECCS, Players, Carbon dioxide removal, Solution, Renewable energy

BOSTON, Oct. 10, 2022 /PRNewswire/ --The Carbon Dioxide Removal (CDR) sector has experienced growing corporate interest and swift development, with record investments over the past year in technologies that draw carbon dioxide (CO) from the atmosphere.

Key Points: 
  • BOSTON, Oct. 10, 2022 /PRNewswire/ --The Carbon Dioxide Removal (CDR) sector has experienced growing corporate interest and swift development, with record investments over the past year in technologies that draw carbon dioxide (CO) from the atmosphere.
  • The new IDTechEx report, " Carbon Dioxide Removal (CDR) Markets 2023-2040: Technologies, Players, and Forecasts ", analyzes the nascent CDR market, discussing the limitations and potential of Negative Emissions Technologies (NETs) to address climate change.
  • Shedding light on such questions, the latest IDTechEx report explores the diverse array of approaches to carbon removal being developed, from nature-based to engineered solutions, the latter including Direct Air Carbon Capture and Storage (DACCS) and Bioenergy with Carbon Capture and Storage (BECCS).
  • IDTechEx's analysis suggests that, with the proper incentives, the global Carbon Dioxide Removal capacity can exceed the gigatonne scale of CO removal by 2040, with multiple approaches that are modest today gaining significant market share in the coming years.

New IDTechEx Report Explores the Carbon Dioxide Removal (CDR) Market Potential

Retrieved on: 
월요일, 10월 10, 2022
Carbon, Adoption, Bioenergy with carbon capture and storage, DACCS, Policy, IPCC, Paris, Climate, Carbon dioxide, Research, Investment, CDR, CO, NETS, Climate change, BECCS, Players, Carbon dioxide removal, Solution, Renewable energy

BOSTON, Oct. 10, 2022 /PRNewswire/ --The Carbon Dioxide Removal (CDR) sector has experienced growing corporate interest and swift development, with record investments over the past year in technologies that draw carbon dioxide (CO) from the atmosphere.

Key Points: 
  • BOSTON, Oct. 10, 2022 /PRNewswire/ --The Carbon Dioxide Removal (CDR) sector has experienced growing corporate interest and swift development, with record investments over the past year in technologies that draw carbon dioxide (CO) from the atmosphere.
  • The new IDTechEx report, " Carbon Dioxide Removal (CDR) Markets 2023-2040: Technologies, Players, and Forecasts ", analyzes the nascent CDR market, discussing the limitations and potential of Negative Emissions Technologies (NETs) to address climate change.
  • Shedding light on such questions, the latest IDTechEx report explores the diverse array of approaches to carbon removal being developed, from nature-based to engineered solutions, the latter including Direct Air Carbon Capture and Storage (DACCS) and Bioenergy with Carbon Capture and Storage (BECCS).
  • IDTechEx's analysis suggests that, with the proper incentives, the global Carbon Dioxide Removal capacity can exceed the gigatonne scale of CO removal by 2040, with multiple approaches that are modest today gaining significant market share in the coming years.

Cubic Transportation Systems Expands Partnership With New England Traffic Solutions

Retrieved on: 
수요일, 9월 21, 2022
Trucking, Rail, Defense, Transport, Military, Public Transport, Other Transport, Safety, Efficiency, Movement, Twitter, C4ISR, Detection, ITS, NETS, Partnership, Cubic Transportation Systems, Solution, Transport, Leadership, New England, Rail transport

ITS WORLD CONGRESS 2022--Today at ITS World Congress 2022 , Cubic Transportation Systems (Cubic) announced its expanded relationship with longstanding partner New England Traffic Solutions (NETS), a provider of advanced technologies enabling the safe, dynamic movement of pedestrian and vehicular traffic.

Key Points: 
  • ITS WORLD CONGRESS 2022--Today at ITS World Congress 2022 , Cubic Transportation Systems (Cubic) announced its expanded relationship with longstanding partner New England Traffic Solutions (NETS), a provider of advanced technologies enabling the safe, dynamic movement of pedestrian and vehicular traffic.
  • We are energized by our evolving work with New England Traffic Solutions, given the teams demonstrated leadership in bringing our ITS solutions to the communities that need them most.
  • NETS offers scalable traffic management solutions, providing agencies of all sizes opportunities to advance their comprehensive transportation management systems.
  • This approach readily complements Cubics integrated transport and traffic management solutions that lay the groundwork today for tomorrows multimodal transportation networks.

Global Nuclear Medicine Market Report 2022: Growing Popularity of Personalized Treatment Fueling Sector - ResearchAndMarkets.com

Retrieved on: 
수요일, 9월 7, 2022
Biotechnology, Pharmaceutical, Health, Curium, Health care, Conditional sentence, Breast, PET, PET-CT, Cancer, Ageing, Gene, Government, SPECT/CT, Death, WHO, Disease, Colon, SPECT, Precision medicine, Person, Lists of countries and territories, Infection, Rectum, Diagnosis, Somatostatin, Radiopharmaceutical, Lung, Nuclear medicine, Neurology, Psychiatry, Society of Nuclear Medicine and Molecular Imaging, CAGR, Population, Adult, Prostate, Copper (64Cu) oxodotreotide, Elective surgery, NETS, Gastroenterology, Genomics, Cardiology, Environment, Patient, Medical imaging

The Global Nuclear Medicine Market is expected to grow at a CAGR of 9.32% and reach USD8804.54 million through 2027.

Key Points: 
  • The Global Nuclear Medicine Market is expected to grow at a CAGR of 9.32% and reach USD8804.54 million through 2027.
  • The growing popularity of targeted radionuclide therapy provides efficacious treatment modalities against cancer.
  • The growing popularity of personalized treatment has significantly increased the demand for nuclear medicine.
  • Thus, the technological advancements
    In this report, the Global Nuclear Medicine Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Artmarket.com presents the Artprice 2022 half-year report: the art market returns to strong growth in the West

Retrieved on: 
화요일, 9월 6, 2022
Digital, Bonhams, Sotheby's, Female, NETS, Sugar Shack, Artcurial, FIAC, Cryptocurrency, CryptoPunks, Thierry Ehrmann, Death, Art market, Sale, Sensation, Fine art, Pressure, Collection, Drawing, Non-fungible token, I Want You (Marvin Gaye album), Living Architecture, NFT, History, Hauser & Wirth, Suggestion, Painting, Grand Palais, Founder, World of Warcraft, Christie's, COVID-19, Marketing, Art Basel, Growth, Continuum, Auction, Film, Artprice

Christie's hammered the 2nd best art auction result of all time at $195 million.

Key Points: 
  • Christie's hammered the 2nd best art auction result of all time at $195 million.
  • Not far behind, the Parisian art market generated $518 million and has attracted a growing number of international institutions.
  • Indeed, this key market indicator has reacted quite differently compared with how it reacted in the last major crisis that affected the global art market, the 2009 financial crisis.
  • She also set a new auction record when her Untitled (Nets) (1959) reached $10.5 million at Phillips on 18 May 2022.

Artmarket.com presents the Artprice 2022 half-year report: the art market returns to strong growth in the West

Retrieved on: 
화요일, 9월 6, 2022
Digital, Bonhams, Sotheby's, Female, NETS, Sugar Shack, Artcurial, FIAC, Cryptocurrency, CryptoPunks, Thierry Ehrmann, Death, Art market, Sale, Sensation, Fine art, Pressure, Collection, Drawing, Non-fungible token, I Want You (Marvin Gaye album), Living Architecture, NFT, History, Hauser & Wirth, Suggestion, Painting, Grand Palais, Founder, World of Warcraft, Christie's, COVID-19, Marketing, Art Basel, Growth, Continuum, Auction, Film, Artprice

Christie's hammered the 2nd best art auction result of all time at $195 million.

Key Points: 
  • Christie's hammered the 2nd best art auction result of all time at $195 million.
  • Not far behind, the Parisian art market generated $518 million and has attracted a growing number of international institutions.
  • Indeed, this key market indicator has reacted quite differently compared with how it reacted in the last major crisis that affected the global art market, the 2009 financial crisis.
  • She also set a new auction record when her Untitled (Nets) (1959) reached $10.5 million at Phillips on 18 May 2022.